COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 385: Articles 3841-3850  | Next

Diverging maternal and infant cord antibody functions from SARS-CoV-2 infection and vaccination in pregnancy
Adhikari, E. H., Lu, P., Kang, Y. J., McDonald, A. R., Pruszynski, J. E., Bates, T. A., McBride, S. K., Trank-Greene, M., Tafesse, F. G., Lu, L. L.
10.1101/2023.05.01.538955 — Posted: 2023-05-02
Discovery and characterization of highly potent and selective covalent inhibitors of SARS-CoV-2 PLpro
Wu, J., Vaid, T., Kim, H., Lu, J., Demissie, R., Lee, H., Fung, L. W.- M., Chen, J., Xi, C., Yang, Z., Huang, Y., Zhang, Z., Zhang, J., Yan, F., Johnson, M. E., Li, M.
10.1101/2023.05.02.539082 — Posted: 2023-05-02
Computational fitness estimates of SARS-CoV-2 mutations affecting spike protein binding to antibodies and ACE2
Thakur, S., Kepp, K. P., Mehra, R.
10.1101/2023.05.01.538902 — Posted: 2023-05-02
Repeated Omicron infection alleviates SARS-CoV-2 immune imprinting
Yisimayi, A., Song, W., Wang, J., Jian, F., Yu, Y., Chen, X., Xu, Y., Yang, S., Niu, X., Xiao, T., Wang, J., An, R., Zhang, N., Wang, Y., Wang, P., Zhao, L., Sun, H., Yu, L., Gu, Q., Shao, F., Jin, R., Shen, Z., Xie, X. S., Wang, Y., Cao, Y.
10.1101/2023.05.01.538516 — Posted: 2023-05-02
Temporal Trend in Mortality from COVID-19 Associated with Cardiovascular Disease
Sarau, A. V., Luo, S., Chen, E. Y.-S., Gawel, S., Desai, P., Tippireddy, N., Saldanha, A., Suboc, T. M., Cloherty, G., Landay, A. L., Volgman, A. S.
10.1101/2023.04.26.23289183 — Posted: 2023-05-01
Characterising subgroups of people with severe COVID anxiety by latent profile analysis.
King, J. D., McQuaid, A., Leeson, V. C., Tella, O., Crawford, M. J.
10.1101/2023.04.28.23289248 — Posted: 2023-05-01
Effect of vaccination on time till Long COVID, a comparison of two ways to model effect of vaccination and two outcome definitions
Smits, P. D., Rodriguez, P. J., Gratzl, S., Goodwin Cartwright, B. M., Gilson, S., Lee, R. H., Baker, C., Stucky, N.
10.1101/2023.04.28.23289271 — Posted: 2023-05-01
The COV50 classifier predicts frailty and future death, independent from SARS-CoV-2 infection
Keller, F., Beige, J., Siwy, J., Mebazaa, A., An, D.-W., Mischak, H., Schanstra, J. P., Mokou, M., Perco, P., Staessen, J. A., vlahou, a., Latosinska, A.
10.1101/2023.04.28.23289257 — Posted: 2023-05-01
Characterization and Resistance to Mutation of a Single-Channel Multiplex PCR Assay for SARS-CoV-2
Pednault, A. L., Swalla, B. M.
10.1101/2023.04.27.23289205 — Posted: 2023-05-01
Mediators of monocyte chemotaxis and matrix remodeling are associated with the development of fibrosis in patients with COVID-19
Holton, S. E., Mitchem, M., Pipavath, S., Morrell, E. D., Bhatraju, P. K., Hamerman, J. A., Speake, C., Malhotra, U., Wurfel, M. M., Mikacenic, C.
10.1101/2023.04.28.23289261 — Posted: 2023-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).